Abstract: Tubulin has received more attention as potent anticancer drug target because it is the fundamental unit of microtubules and plays an active role in cell division. The drugs against -tubulin are mainly derived from terrestrial plants and marine resources. Of these, red and brown algae from the marine environment produce better secondary metabolites. These compounds are found to be active against cancer cell lines. Since there is no study reported till date about the activity of these compounds against human -tubulin, we have investigated the role of 517 compounds available in the seaweed secondary metabolites database against modeled human -tubulin. All the conformers of lead compounds (RL381, RL366, RL376 and RG012) when docked at the taxol binding site showed better interactions with the H1-S2 loop and M-loop which are actively involved in lateral interactions of tubulins and also with the helix H7 which is the connecting link between N-terminal and intermediate domain. Important residues involved in polar interaction by these lead compounds were D224, H227, R276, R282 and R359 which closely mimicked the interaction of taxol with -tubulin. We then attempted to calibrate the available molecules based on their Lipinski rule, binding affinity and other descriptor based comparison to identify potential lead molecules which could be used as drugs against human tubulin.
INTRODUCTION
Microtubules (MT) -cytoskeletal filaments found in all eukaryotic cells, play a pivotal role during chromosomal segregation, motility, vesicular and intracellular transportation [1, 2] . Hence, they are potential antitumor drug target for taxanes, epothilones, colchicine and vinca alkaloids [3] . The basic building blocks of microtubules are assembled by heterodimeric / tubulin monomers, which are further non-covalently organized into 13 protofilament structures longitudinally arranged in a head-to-tail formation to form a closed tube [4, 5] .
/ tubulin duo belongs to the broad class of GTP binding proteins and have a 40% sequence identity [16] . Both the subunits show a slight structural variation from the conventional GTPases, whereas the functional domains are well conserved. The N-terminal domain includes a nucleotide binding site comprising of six parallel strands (S1-S6) altered with the same number of helices (H1-H6). The intermediate domain has mixed strands (S7-S10) and three helices (H8-H10). This region is connected to the Nterminal domain by the helix H7 and contains a hydrophobic taxol binding pocket. The C-terminal domain, which is a binding surface for motor protein, is formed by two antiparallel helices (H11-H12) crossing over the two other glycoprotein and mutations in -tubulin resulting in resistance to it [31] [32] [33] . Additionally, the vinca structure allows only minor alternations, and the potencies of colchicine derivatives are rather low [34] [35] [36] [37] . These disadvantages associated with taxane, vinca and colchicine initiated a search for lead compounds that can mimic their mechanisms of action. From ancient times, terrestrial plants were considered as a source of medicine, leading to the identification of taxol, vinca alkaloid, podophyllotoxin and camptothecin in recent times as drugs against cancer [38] . Recently the focus has shifted to marine metabolites as potential anticancer drugs against tubulin [39] .
Marine chemicals have novel structures with pronounced biological activity and pharmacology [40] . Seaweeds are among the first marine organisms chemically analyzed, which have more than 3,300 secondary metabolites from marine plants and algae with potent biological activities. Red and brown algae are the better producers of secondary metabolites, wherein the former are better than the latter. Red algae of the genus Laurencia (Ceramiales, Rhodomelaceae) are some of the most prolific producers of secondary metabolites in the marine environment. Secondary metabolites from these algae are predominantly sesquiterpenes, diterpenes, triterpenes and C15-acetogenins characterized by the presence of halogen atoms in their chemical structures. Most Laurencia species accumulate a characteristic major metabolite or a class of compounds not widely distributed within the genus [41] . Thus Galaxaura marginata and Laurencia obtusa secondary metabolites are known to be prominent cytotoxic compounds. But till date, secondary metabolites are not reported against humantubulin. Data mining for potential marine derived lead compounds led us to the seaweed metabolite database (SWMD) which consists of 517 compounds from red algae [42] [43] [44] [45] . This paper investigates the potential secondary metabolites against human -tubulin identified by virtual screening of SWMD. The Taxol binding site was targeted with the conformers of secondary metabolites to identify potential lead compounds. Thus, four lead compounds (RG012, RL381, RL366 and RL376) were identified which showed good binding affinity with tubulin.
METHODS

Homology Modelling
The query sequence of human -tubulin was retrieved from the Swiss-Prot protein database (accession number Q9BVA1.1) [46] . In the absence of the crystal structure of human -tubulin, BLAST [47] search was done against Protein Data Bank (www.rcsb.org) [48] . PDB ID: 1TUB obtained from the Protein Data Bank was taken up as a template for modelling of the query sequence. Using the single template protocol of Modeller9v10, 30 structures were generated [49] . Amongst these, the model with the least DOPE score (Discrete optimized protein energy) was considered for energy minimization with 500 iterations using steepest descent in SwissPdb Viewer [50] . The optimized structure was further validated using SAVES server (http://nihserver.mbi.ucla.edu/SAVES/) [51] .
Library Generation
In continuation, drug like compounds were derived from the SWMD database (www.swmd.co.in) which comprises of 517 entries mostly from the red algae of the genus Laurencia (Ceramiales, Rhodomelaceae). The MOL file (2D structure) of each compound was prepared with Ligprep tool (Schrodinger 9.2) to generate multiple conformers at physiological pH (7.0) [52] . The availability of different conformers in their native state and exploration of their conformational search space by altering torsion angle values, led to the detection of 2382 conformers from 517 compounds. 
Docking Studies
-tubulin protein was prepared using 'protein preparation wizard' of Schrodinger 9.2 at physiological pH. All the 2382 generated conformers were docked at the taxol binding site of -tubulin along with taxol, eleutherobin and Sarcodictyin A. The binding site was generated using receptor-grid generation protocol of Glide by selecting the centroid of taxol for grid file generation. A scaling factor of 1.0 was set to van der Waals (VDW) radii for the atoms of residues that presumably interact with ligands and the partial atomic charge was set to less than 0.25. The initial screening of 2382 conformers was done using Glide HTVS (High Throughput Virtual Screening) which filtered 1955 conformers with better spatial restraints. By keeping the cut off glide score above -4.0 kcal, 1955 conformers were brought down to 999 conformers. These selected conformers were subjected to Glide extra precision (XP) mode of docking which does extensive sampling and provides reasonable binding poses [53] . The pharmacokinetic properties of 999 conformers were assessed using Qikprop to calculate the ADME properties of the compounds which includes physically significant descriptors and pharmaceutically relevant properties [54] . The Qikprop properties considered for analysis include glide score, glide energy (kcal/mol), molecular weight (g/mol), molecular volume (Å), PSA, HB donors, HB acceptors, rotatable bonds, QP logP(o/w), QP logS, QP PCaco, QP logHERG, QP PMDCK and % human oral absorption.
RESULTS AND DISCUSSION
The present study focuses mainly on identifying potential lead compounds against human -tubulin. The search for lead compounds was carried out from the seaweed marine database (SWMD). In the absence of the 3-D structure of human -tubulin, a comparative model was generated. Virtual screening approaches were used for selecting potential inhibitors against human -tubulin. The first step involved the generation of conformers of the secondary metabolites from the seaweed database using Ligprep. These native conformers were docked on the taxol binding site. This step was carried out in two modes, HTVS and XP. In HTVS mode, the conformers of ligands that do not spatially fit into the binding site were eliminated. For the seaweed metabolite database, out of the total 2382 conformers, 1955 conformers passed through HTVS screening. XP (Extraprecision) docking mode is a refinement tool which consumes considerably more CPU time. Hence, only the top scoring 999 conformers (above -4.0 kcal/mol) of the total 1955 conformers were selected for XP mode docking.
The top 21 lead compounds with best conformers were selected based on their GlideXP scores. Interestingly, 11 out of the 21 structures reported to be cytotoxic [42] , exhibited better binding interactions Table (1) . The biological activity (cytotoxic) of these compounds has been reported against P388 (leukemia), KB (cervical carcinoma), A549 (non small lung carcinoma), HT29 (colon adenocarcinoma) and HeLa cancer cell lines expressed as ED 50 and IC 50 [43, 59] . Four out of 11 compounds (RL381, RL366, RL376 and RG012) were selected as a lead compounds based on interactions with either H1-S2 loop, M-loop or S-loop of -tubulin Fig.  (2) . These compounds were extracted from Laurencia obtuse and Galaxaura marginata species. The chemical names of the four lead compounds are diterpenes containing bromine (RL381), 15-epi-prostaglandin A2 diester (RL366), diterpenes containing bromine (RL376) and 6 , 24 -dihydroxycholesta-4, 25-dien-3-one (RG012). Fig. (3) depicts the molecular interactions of four lead compounds with -tubulin. Compound RL366 forms H-bonds with S25 and Q43 which is the H1-S2 loop actively involved in lateral interaction. Conversely, R359 which is in the S-loop region is also preferred for binding [55] . Compound RG012 prefers binding to H227 and R224 which are actively involved in nucleotide binding (H7 helix) and to R359 which is in the Sloop. Similarly, RL381 interacts with H227, R276, R282 and R359, while RL376 shows interactions with H227, T274 and R282. Thus all these compounds mimic the interaction of taxol with -tubulin through their polar contacts [17] . Table  ( 2) describes the atoms of residues from -tubulin involved in interactions with the lead compounds.
As the taxol binding site is also occupied by eleutherobin [29] and Sarcodictyin A [56] , our study mainly emphasized on comparative binding analysis of taxol, eleutherobin and Sarcodictyin A against the four identified lead compounds. Qikprop study considered significant descriptors and pharmaceutically relevant properties to categorize the four lead compounds The biological activity of four lead compounds was obtained from SWMD database. For RL376 and RL381, cytotoxicity was not reported against any cell line and for RL366 the cytotoxic activity was reported as IC 50 . Therefore, the ED 50 value of RG012 was used to compare the ED 50 of taxol [57] and Sarcodictyin A [58] . As evident from Table 1 , RG012 exhibited more potency in the range of 0.19 -2.37 ED 50 (μg/mL) as compared to ED 50 of taxol (ED 50 = 26.41 μg/mL) and Sarcodictyin A (ED 50 = 0.993 μg/mL). The remaining seven compounds eliciting cytotoxicity can also be considered as lead compounds upon modification of functional groups. Thus, based on the known biological activity and pharmacokinetic parameters, the lead molecules can potentially be targeted against -tubulin and can be taken one step ahead in experimental designing of anti -tubulin compounds.
CONCLUSION
Since the existing drugs show high toxicity, a search for novel lead molecules is underway to identify better drugs directed against human -tubulin protein. Here, we tried to identify lead compounds from marine seaweed secondary metabolites which target the taxol binding site of humantubulin. Molecular interactions shown by these compounds mimic the interactions of taxol against -tubulin. In addition to this, the regions of contacts were with the loops which are actively involved in lateral contacts between two monomeric tubulin subunits. Comparison of these compounds with existing drugs and those in the pipeline confirms better drug like properties from the perspective of their molecular weight, binding affinity and other related descriptors. Thus, we conclude that these lead compounds can be tested experimentally against human -tubulin to obtain potential drug molecules.
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Introduction
Microtubules are the cytoskeletal filaments actively involved in chromosomal segregation, motility, intracellular transportation and cell division 30 . Tubulin forms the fundamental unit of microtubules which is a hetero dimer made up of α-and β subunits with ~450 amino acids each. In spite of their structural similarity, they exhibit only 40% sequence identity 43 . Both the subunits get well associated with GTP; however, hydrolysis is restricted to β subunit resulting in GDP formation at the exchangeable site. However it gets sequestered in non-exchangeable site in αsubunit 1,13,29,36,40,42,46,48. This event results in curved protofilaments formation compared to the straight one with intact GTP. Further the GTP hydrolysis unlocks the polymer structure, resulting in microtubule disassembly which otherwise locks helix H7 in the straight position. 9, 55 Throughout this event β tubulin was found to exhibit major conformational changes compared to α subunit in monomeric form. Both these subunits exhibit lateral as well as longitudinal contacts in a head to tail formation. The lateral contacts involve the interaction of H1-S2 loop with M loop from the adjacent protofilament 18, 63 .
Each monomer consists of three distinct domains which include the N-terminal domain, intermediate domain and Cterminal domain. The N-terminal domain harbors the nucleotide, and has 6 parallel beta strands (S1-S6) along with the same number of alpha helices (H1-H6). The intermediate domain has strands S7-S10 with three helices H8-H10 which accommodate taxol. The C terminal is made up of two antiparallel helices H11-H12 which interact with microtubule associated protein (MAP). 11 Even though the overall domain architecture remains the same in α and β tubulin, still they differentiate themselves both sequentially and structurally. Two positional gaps were observed in β-tubulin at H1-S2 loop (45-46) (GG) and S-loop (361-368) (TVVPGGDL). The gap in the latter is due to an eight residual deletion which gets well accommodated by taxol 47 ( Figure 1 ).
The active role of tubulin protein in cell division makes them a potential anticancer drug target 28 . They have three distinct binding sites which include taxol binding site, colchicine binding site and vinca alkaloid binding site. Drugs that interact with taxol binding site include paclitaxel, epothilone, docetaxol and discodermolide. Colchicine binding site harbors colchicine, combrestatin, 2-methoxy estradiol and methoxyben benzenesulfonamides (E710). Vinca alkaloids binding site favors vinblastine, vincristine, vinorelbine, vinfluine, dolastatins, Res. J. Biotech (21) halichondrins, hemiasterlins and cryptophysin-52 8,24,31,35. All these drugs are religiously involved in inhibiting cell division through either polymerization or depolymerization 51 . There is a report of drug resistance against all these drugs 5, 49 . Many factors has been cited for drug resistance which includes changes in cellular drug uptake, drug metabolism, structural changes in the drug target, drug efflux, tubulin expression patterns with low pglycoprotein activity and residual mutations in β-tubulin. 5, 14, 32, 41, 50 Given the high incidence of tubulin mutation as a cause of drug resistance in these studies, the question of whether tubulin mutation brings in drug resistance is a matter of debate in recent years 3 . The residues listed for drug resistance in β-tubulin include D26E, V60A, S172A, P173A, A185T, D197N, E198G, A231T, L240I, A248V, F270V, T274P, T274I, R282Q, Q292E, R306C, K350N, S364T and Y422C [19] [20] [21] [25] [26] [27] [28] 34, 53, [61] [62] [63] [64] [65] . All these substitutions are due to nsSNP (nonsynonymous SNP) substitution which brings in change in amino acid.
Through this study we tried to investigate the significance of eight residual deletions in β-tubulin from sequential and structural perspective for both α-and β-subunits. Here the effect of eight residual insert in α-tubulin and their deletion in β-tubulin was investigated separately through molecular simulation, residual bulkiness analysis, hydrogen bonding pattern and protein-protein interactions. This was followed by understanding the effect of amino acid substitution in drug resistance in human β-tubulin. Thus the better understanding of molecular dynamics and the residual substitution in β-subunits could help us in better drug designing against cancer with reduced drug resistance.
Material and Methods
Sequence Analysis for residual bulkiness in α and β tubulin: To begin with, α and β tubulin sequences were downloaded from SwissProt database (α-P68363) (β-Q9H4B7) 2 . These two sequences were aligned using ClustalW software 7 to generate Pairwise alignment. The alignment confirms the two site deletions of residues at H1-S2 loop and S-loop as stated by Nogales 47 ( Figure 2 ). Next the residual bulkiness of each sequence was separately investigated using ProtScale 17 . The window size was averaged at nine residues. Rest of the parameters was set at default and the results were analyzed. The generated peak signifies the level of bulkiness exhibited by the regions closely involved in lateral interaction like H1-S2 loop, M loop and the S-loop. Here we considered the S-loop as their presence (in α-tubulin) and their deletion (β-tubulin) needed further investigation.
Molecular simulation: Sequence analysis was followed by the structural analysis wherein the molecular dynamic simulation of α and β tubulin of Sus Scrofa was considered for analysis. The coordinate file (1TUB) was downloaded from Protein Databank (www.rcsb.org/pdb) 46 . Chain A and B of this coordinate file was individually considered for molecular simulation using Desmond software 56 . Both the coordinate files were solvated with water molecules in a dodecahedron box with Spc216 as solvent configuration for SPC/E. All protein atoms were at a distance equal to 1.0nm from the box edges. To ensure that the system has no steric clashes or inappropriate geometry, the system was subjected to energy minimization for 5000 steps by steepest descent to achieve native conformation.
Equilibration of solvent and ions around the protein is achieved using NVT ensemble at constant temperature. The minimized system was equilibrated for 50 ps each at 300K by position restrained MD simulation to relax the system. The equilibrated systems were then subjected to MD simulations for 1000 ps each at 300K. The generated trajectory files were analyzed for their RMSD (Root Mean Square Deviation) and RMSF (Root Mean Square Fluctuation) to understand the level of flexibility exhibited by the peptide segments involved in lateral interactions like H1-S2 loop, and M-loop. Here too S-loop region was also considered as their deletion in β-subunit needed further investigation in comparison with α-subunit. Hydrogen bonding pattern of S-loop in α and β subunits: To understand the reason behind the flexibility and the rigidness of the peptide segments closely associated with lateral interactions we did hydrogen bonding pattern analysis of both α and β subunits. The peptide segment considered for hydrogen bond analysis is the S-loop 358-372 in α tubulin and 356-363 in β tubulin. As such not much has been reported on the intramonomeric interaction this study would help in understanding the reason behind the difference in the flexibility of the loops associated with lateral interactions in α and β subunits. Thus through this study we tried to understand the role of the eight residual inserts (TVVPGGDL) in stabilizing the peptide segments associated with the lateral interactions. All the generated interactions were investigated using SwissPdb viewer 22 .
Protein-Protein docking: Docking studies of this kind could assist in understanding the significance of flexibility and residual bulkiness of protein in binding of monomeric subunits. Thus protein-protein interactions to study the strength of lateral contacts between α-α and β-β subunits were carried out using HADDOCK server (High Ambiguity Driven protein-protein DOCKing) with easy interface 10 . The active residues selected for the docking studies include H1-S2 loop region (residues 24-63) and M loop (272-288) 47 . Further the passive residues were automatically selected which are proximal to the active residues. The generated results were investigated for their binding energy.
Residual mutation and Drug resistance: Molecular dynamics shed light on the level of flexibility of the the functionally significant regions in tubulin which plays active role in drug binding. While residual substitution assists in understanding the significance of individual residue in structural stability and drug interaction. Even though some of the literature survey supports the residual substitution associated with drug resistivity in β-tubulin protein but still the controversy looms over the exact role of such mutants in in-vivo resistivity.
The main reason behind this is the inclusion of nonfunctional β-tubulin pseudogenes 3 . Here we tried to investigate the significance of each residual mutation and its impact on drug resistance using Amino Acid substitution prediction methods (AAS). Literature survey reports eighteen positional substitutions which result in drug resistance. 12, 15, 34, 44, 52, 54, 59 For this we made an attempt to identify deleterious nsSNPs which bring in amino acid change which ultimately brings in drug resistance.
Here we considered three Amino Acid Substitution tools which include Polyphen2 (polymorphism phenotyping) 57, 58 , PANTHER (Protein analysis through evolutionary relationship) 60 and I-Mutant2.0 6 for investigating the effect of residual substitution on drug resistance in human β-tubulin. The amino acid sequence for the same was downloaded from Swissprot database (Accession number: Q9H4B7). Here, Polyphen (polymorphism phenotyping) uses information about the structure of the protein hydrophobicity, charge effects and changes in molecular contacts based on available structural data from Protein Data bank and multiple sequence alignment.
The results were displayed based on Position Specific Independent Count (PSIC) score difference, the variant is predicted to be probably damaging or possibly damaging or benign with respect to the score of >2.0, >1.5 and <1.5 respectively. Next, PANTHER (Protein analysis through evolutionary relationship) is based on HMM to validate the impact of mutation single point mutation. Finally I-Mutant 2.0 was used for mutant analysis which is based on structure based approach on support vector machine. Here a score less than "0" means the mutation decreases the stability whereas the score more than "0" means the mutation increases the stability.
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Results and Discussion
Residual analysis for Bulkiness for α and β tubulin: The bulkiness of amino acids present in H1-S2 loop, M-loop and S-loop was investigated in α and β tubulin. Study confirms less bulky residues in H1-S2 and M loops with the values lesser than 16 in α-tubulin. S-loop is found to be more bulky with the value >16. It is just the reverse in case of β-tubulin with bulky H1-S2 and M loops with peak values >16 and reduced bulky S-loop region with a value < 16. (Table 1 . α-tubulin shows a stable RMSD compared to the β-tubulin as evident from figure 4. The RMSF plot of H1-S2 loop is highly flexible for α-tubulin whereas the M-loop is quite rigid. The reverse is observed in the β-tubulin wherein the H1-S2 loop is quite rigid and the M-loop is flexible. Conversely, S-loop proximal to Mloop is flexible in α-tubulin whereas it is rigid in β-tubulin (Table 1) . Hydrogen bond analysis: Generally all the available literature survey reports inter protofilament subunit interactions. Not much has been discussed about the intramonomeric subunit interaction. Through this study we inspect the hydrogen bonding pattern of S-loop with their neighboring regions. For α-tubulin, we observed that the residual interaction observed between M and S-loops include D367 with A278. A369 interacts with I276 and Q372 and R373 interacts with Q285. In β-tubulin a single salt bridge was observed between R359 (S-loop) and E27, D39 (H1-S2 loop) (Figure 6 a, b ). All these above mentioned interactions were observed between the side chains.
Prediction of docking result:
As the lateral interactions are observed between H1-S2 loop and M-loop of the adjacent protofilament in α and β subunits; we did their docking through HAADDOCK software to understand their level of interactions. As the total binding energy (Gbinding) is the sum of the intermolecular van der Waals and electrostatic energies, we considered both of them for analysis 39 . Van der Waals interaction for α-tubulin is -30.6 +/-8.0 kcal/mol while electrostatic interaction is -425.4 +/-82.2 kcal/mol. For β-tubulin the van der Waals energy score is -47.8 +/-1.4 kcal/mol and the electrostatic energy score is -302.3 +/-29.3 kcal/mol. Thus the summation of these two favors α-α compared to β-β tubulin subunits. (For α-GTP the summation score is -456.0 kcal/mol whereas for β-GDP it is -350.1 kcal/mol.). This finding confirms the statement put forth by Downing et al 11 .
Prediction of drug resistance using amino acid substitution tools: All the available mutants in human β-tubulin were investigated using the Amino acid Substitution (AAS) tools like PANTHER, Polyphen2 and IMutant 2.0. This study was mainly instigated to identify those mutants which ultimately bring in protein instability which might ultimately result in drug resistance. But before that the nsSNPs which result in change in amino acids in 18 positions were investigated for their base change. The first codon position showed eleven base substitutions whereas the second position showed four substitutions and finally the third position showed only two substitutions. In addition to this there are ten transitions and eight transversions observed during substitutions ( Table 2 ).
The consensus reports of the AAS generated results were investigated here. Residual mutants at V60A, D197N, L240I, F270V, K350N and A364T are unanimously considered as deleterious by all three software. While mutants P173A, Q292E, R306C, Y422C are predicted to be deleterious by two software (Table 3) , their positions were identified in the β-tubulin. All these residues identified to be deleterious viz. H1-S2 loop, helix H5, T6 loop, B7, B7-H9 loop, helix H9, H10-B9 loop, H9-B8 loop and helix H12 were found to occupy functionally significant regions. To start with, H1-S2 loop is actively involved in lateral interaction 47 . T6 loop is essential for rotation movement from straight to curved structures in protofilaments of β tubulin 55 . Beta B7 has a strong hold with the N-terminal domain. While the loop connecting B7-H9 is involved in lateral interactions 46 , the residue from helix H9 (Q292) makes active interaction with S275 to stabilize M loop 61 . H9-B8 loop may affect the lateral contact loop 23 . Y422 from helix H12 plays significant role as a site of attachment for motor proteins. Both H5 and H12 also exhibit lateral interactions with M-lop in zinc sheets 47 . H10-B9 loops interact with each other and compete for interactions with positively-Res. J. Biotech (26) charged residues of the H11 helix on the neighboring monomer 16 .
Thus to summarize, here we report the significant role of eight residual insert (TVVPGGDL) and their deletion in α and β tubulin respectively. An eight residual deletion is restricted to β-tubulin which is present in α-tubulin. This needed to be investigated from sequential and structural perspective. Thus our study started with the identification of residual bulkiness in both α and β subunits. Sequence based bulkiness analysis for α-tubulin reports less bulky H1-S2 and M-loops with a more bulky S-loop. Conversely in β-tubulin the residual bulkiness of H1-S2 loop and Mloop is higher, while the S-loop region maintains less bulkiness. Root Mean Square Fluctuation plot generated after molecular simulation reports flexible H1-S2 and Sloops with rigid M-loop in α tubulin.
One of the main reasons behind this is the presence of less bulky residues in the H1-S2 loop. Inspite of presence of less bulky residues in the M-loop still they exhibit rigidness because of their interaction with the S-loop through hydrogen bonds. In β-tubulin there is a restricted flexibility observed for H1-S2 loop. As already mentioned these regions harbor more bulky residues. Apart from that there is a salt bridge formation observed between the S-loop and H1-S2 loop. Further we observed that the flexibility of the H1-S2 loop is much needed for the better protein-protein interaction which is quite well observed between α-α subunits.
The rigidness of the H1-S2 loop due to the intramonomeric interaction with S-loop ultimately brings in reduced binding energy between β-β subunits. With this restricted mobility of the H1-S2 loop in the β-tubulin there is a reduced binding affinity observed between β-β monomeric subunits. Next, the residual substitution related to drug resistance when investigated through Amino Acid Substitution tools confirms the mutations to be deleterious when they are observed in the functionally significant regions like the region of lateral interaction and dimer interface which might ultimately bring in drug resistance. Thus the better understanding of the tubulin dynamics and residual substitution could assist in better drug designing. In addition to this, the drugs with their interactions with H1-S2 loop along with M-loop and S-loop could assist in better stability of lateral interactions which could ultimately arrest cell division. Such type of compounds can be a potential drug against cancer. 
Introduction
Tubulin being the fundamental unit of microtubules is critically involved in chromosomal segregation, cell division, motility and intracellular transportation (1) . They are made up of α and β subunits alternatively arranged in a lateral and longitudinal manner. The lateral contacts involve the interactions of H1-S2 loop and Helix H3 with the M-loop of the adjacent protofilament. Thus 13 protofilaments associates laterally and are found to be more electrostatic and less hydrophobic than the longitudinal contacts (2) (3) (4) (5) (6) (7) . The alternative arrangement of α and β subunits results in longitudinal interaction which are classified into intera and interdimer interfaces. The intera dimeric interface is observed between β and α subunits whereas the interdimeric interface is found between α and β subunits (8) (9) (10) . Further, the longitudinal contact involves the interaction of H8 of α tubulin with H11-H12, T5, T3 and γ-phosphate of the adjacent subunit. Similarly T7 of α-tubulin shows interactions with phosphates T2, T1, H7 and Guanine (11) .
β-tubulin subunit comprises of three distinct domains which include the N-terminal domain, intermediate domain and C-terminal domain. The N-terminal domain harbors the nucleotide, and has 6 parallel beta strands (S1-S6) along with the same number of alpha helix (H1-H6). The intermediate domain has strands S7-S10 with three helices H8-H10 which accommodates taxol. The C-terminal is made up of two antiparallel helices H11-H12 which interacts with microtubule associated protein (MAP) (12) .
Even though the overall domain architecture remains the same in α and β tubulin, still they differentiate themselves both sequentially and structurally. Sequentially they relate through 40% residual identity. While structurally two positional gaps were observed in β-tubulin at H1-S2 loop (45) (46) and S loop (361-368). The larger gap in β-tubulin gets well accommodated by taxol (13) . Both the subunits get well associated with GTP; however, hydrolysis is restricted to β-subunit resulting in GTP formation at the exchangeable site. However it gets sequestered in nonexchangeable site in α subunit (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) .
Tubulin with their active role in cell division has been considered as a potential anticancer drug target (25) . They comprise of three distinct drug binding domains which includes taxol, Vinca alkaloid and colchicine binding sites. Drugs associated with these sites were religiously involved in arresting the mitotic spindle formation (26) . Further taxol and colchicine share overlapping residual interactions towards the inner surface of the microtubules (27) .
Paclitaxel being the powerful drug for treating several solid tumors including breast, ovarian and non-small cell lung carcinomas (28) prefers to bind with M-loop proximal to S loop resulting in stabilization of lateral interactions of two adjacent protofilaments (29) . The important residues associated with taxol binding include V23, D226, H229, T276, R278, R369 and Gly370. These residues were scattered around H1-S2 loop, H7, M-loop and S-loop (30) . Apart from Paclitaxel, epothilones A and B, eleutherobin and discodermolide has also been reported to bind to the taxol binding site (31) .
Inspite of all these drug interactions, there is a report of drug resistance associated with these drugs. The main reason being cited is the residual substitutions associated with the drug resistivity. Even though literature supports the correlation between the residual substitutions with drug resistance, but still there is also a controversy over their role because of the inclusion of pseudogenes being considered during drug resistivity analysis (32) . Thus the debate on the role of residues on drug resistivity remains elusive. The reported residual mutations in human β tubulin includes D26E, V60A, S172A, P173A, D197N, E198G, A231T, L240I, F270V, T274P, R282Q, Q292E, R306C, K350N, A364 and Y442C. The resistances have been observed for the drugs like taxol, epothilone, Hemiasterlin, 2-Methoxyestradiol, Vinca alkaloids and Indancocine (33) (34) (35) (36) (37) (38) (39) .
Previous study reports about drug resistance and its reduced binding affinity for the available drugs, but still not much has been discussed about the drugs which were targeted against the mutant proteins. In this paper, we tried to target the available chemical compounds from higher plants, lower plants and seaweed secondary metabolites against wild and the mutants of human β-tubulin to investigate their level of interactions.
Materials and methods
To begin with, human β tubulin sequence was downloaded from SwissProt database (accession number: Q9BVA1.1) (40) . With no reported crystal structure of human β-tubulin till date, a BLAST-PDB based (41) search was carried out to identify suitable templates. Out of the reported hits, 1JFF was downloaded from Protein Data Bank (www.rcsb.org) (42) which was further considered as a template (1JFF-B chain) for the modelling of the query sequence.
Pairwise alignment of the template and the query sequence was generated using Modeller9v10 (43) (Figure 1 ). Using single template protocol from Modeller, 30 structures were generated. Of these generated structures, the model with the least DOPE score (Discrete Optimized Protein Energy) was considered for energy minimization with 100 iterations using steepest descent in SwissPdbViewer (44) . The template and the modelled structures were superimposed with each other (Figure 2 A-C) . The DOPE score of the template was -49714.55 and the modelled structure was -55870.25. The optimized structure was further validated using PROCHECK of SAVES server (http://nihserver.mbi.ucla.edu/SAVES/) (45) . Similar methods were followed for the generation of mutants F270V, A364T and Q292E respectively.
Conversely, chemical compounds needed for the docking against wild and the mutants of human β-tubulin were obtained from marine flora. The chemical compounds were obtained from seaweed secondary metabolite database (www.swmd.co.in) (46) . All these available compounds were isolated form Red algae Laurencia obtuse (RL) and Galaxaura marginata (RG type). Some of these compounds were reported to be cytotoxic against cancer cell lines (47) (48) (49) (50) (51) . During our previous study, out of the 517 compounds, we could identify four lead compounds named RG012 (6β, 24ε-Dihydroxycholesta-4, 25-dien-3-one), RL381 (diterpenes containing bromine), RL366 (15-epi-prostaglandin A2 diester), and RL376 (diterpenes containing bromine) which exhibits better binding with wild type human β-tubulin protein (52) . All these selected compounds were taken into consideration for docking against the wild and mutant human β-tubulin proteins in the current study.
Next, through literature survey we identified chemical compounds both from higher and lower plants. To begin with, the compounds from higher plants includes Berbamine, Butulinic acid, Camptothecin, Cucurbitacin, Ellipticine, Flavopiridol, Homoharringtonine, Silvestrol, Berberine, Daphnoretin and Podophyllotoxin. Regarding their sources, Berbamine is extracted from Berberis vulgaris with a reported apoptosis in human myeloma cells (53, 54) . Betulinic acid is a pentacyclic triterpenoid with reported antiretroviral, antimalarial and anti-inflammatory activity and anticancer properties extracted from the bark of Betula pubescens (55, 56) . Camptothecin isolated from the bark and stem of Camptotheca acuminate is a cytotoxic quinoline alkaloid which inhibits the DNA enzymetopoisomerase I (57) . Cucurbitacins are identified from the family of Cucurbitaceae with anti-cancer and anti-inflammatory activities (58) . Podophyllotoxin is a nonalkaloid toxin lignan extracted from the roots and rhizomes of Podophyllum species which is again an antitumor agent (59) (60) (61) Silvestrol, is isolated from Aglaia foveolata with a report of resulting in apoptosis in the cell lines of hormone-dependent human prostate cancer (62) .
Homoharringtonine is extracted from Cephalotaxus harringtonia which is identified to be a cytotoxic alkaloid which is generally reported to block the progression of cells from G1 phase in to S phase and G2 phase into M phase (63) . Flavopiridol is an indigenous plant from India, which has reported arresting of cell cycle progression at the G1/S and G2/M boundaries (64) .
Daphnoretin obtained from Wikstroemia indica exhibits strong antiviral and anti-tumour activities with a report of cell cycle arrest in the G2/M phase (65) . Ellipticine is isolated from Apocyanaceae plants with established antitumor and anti-HIV activities with their limited toxic side effects and their lack of hematological toxicity (66) .
Regarding lower plants, Aclarubicin is produced by Streptomyces galilaeus actively used in the treatment of cancer (67) . Daunorubicin and its derivative doxorubicin are antitumour anthracycline antibiotics produced by Streptomyces peucetius (68) .Blasticidin is potent antifungal and cytotoxic peptidyl nucleoside antibiotic from Streptomyces griseochromogenes which plays a significant role in controlling prokaryotic and eukaryotic cell growth (69) . Chartreusin is a potent antitumor agent with a mixed polyketide-carbohydrate structure produced
by Streptomyces chartreusis (70) . Neothramycin has been isolated from Streptomyces MC916-C4 which is a potent antitumor antibiotic of the pyrrolo(l,4)benzodiazepine group (71, 72) . Pirarubicin is an anthracycline drug has a diversified antitumor activity (73, 74) . All these chemical compounds were downloaded from Pubchem database. The chemical structures were obtained from chemical book (www.chemicalbook.com) ( Table 1 ). The summary of the chemical compounds of lower and higher floras along with marine derivates are tabulated in Table 2 .
All these selected compounds were charged using gasteiger charges available with CHIMERA software (75) . Energy was minimized using PRODRG and hydrogen atoms were added to them. Then these compounds were considered for docking using iGEMDOCK software (76) . The active sites of taxol (V23, D226, H229, T276, R278, R369 and Gly370) and epothilone (H227, A231, T274, R276, R282 and Q292) (77) were selected for docking ( Figure 3) . Next, only the residual mutants with deleterious effects were considered for homology modelling. This was identified using Amino acid substitution (AAS) tools like Polyphen2 (polymorphism phenotyping) (78, 79) PANTHER (protein analysis through evolutionary relationship) (80) and IMutant2.0 (81) .The list of residual substitutions which brings in deleterious effects are tabulated (Table 3) . (For detailed report refer (82) ). Out of ten deleterious sites identified, only three were selected as these substitutions were found to be proximal to the drug binding sites.
Unfortunately, rests of the positions were located at distal sites of both taxol and epothilone binding sites. Docking of the lower and higher plants along with marine isolates were carried out using iGEMDOCK for taxol-wild, taxol-mutants (F270V, A364T), epothilone-wild and epothilone-mutant (Q292E). The docking study follows the accurate docking protocol which was very slow with their population size of 800 with the number of solution to be 10. The generation number was maintained at 80. Similar protocol was followed for taxol and epothilone binding pockets. Finally, we measured the size of the normal grooves for wild and the mutants of taxol and epothilone binding sites using SwissPdbViewer. 
Results
In
Discussion
During the docking of the wild and the mutants against the available compounds, only three mutants were generated which were proximal to the drug binding site, and were also reported to be lethal. Thus the generated mutants were christened as mutant1 (F270V) mutant2 (A364T) for the taxol binding site. Similarly, mutant (Q292E) for epothilone binding site.
Docked structures were separately investigated for their interactions using CHIMERA software.
Here we observed that Neothramycin exhibits interactions with the taxol binding site through P272 and R276 ( Figure 5A ). Similar interactions were exhibited by the mutant1 ( Figure 6A ).
While mutant2 exhibited interaction with L361 ( Figure 6B ). Likewise RL381 displayed interactions in the wild type of taxol binding site with H227, R282, and R359 ( Figure 5B ).
Camptothecin shows interaction with T274 ( Figure 5C ) while, taxol based mutants irrespective of its higher binding energy, does not display any interactions. Ellipticine also confirms no significant binding in mutant2. Flavopiridol does not show any significant interactions in the wild taxol binding site. But mutant1 shows interaction with H227 ( Figure 6C ). While mutant2
shows interactions with T274 and A275 ( Figure 6D ). Berberine also shows no significant interaction in the wild type and mutant2 of taxol binding site but mutant1 confirms their interaction with R276 ( Figure 6E ). Again with Daphnoretin, both wild and mut2 shows no interactions, but mutant1 interacts with R276 ( Figure 6F ). Next, regarding the epothilone binding site, Neothramycin binds with mutant at T274 ( Figure 7A ). RL366 interacts in the mutant with R276 ( Figure 7B ). While the rest of the compounds like RL381, Flavopiridol, Berberine and Daphnoretin exhibited no significant interactions. With no remarkable change in the pattern of interactions both in wild and the mutant, we considered the groove analysis for the taxol and the epothilone binding site. This study confirms an increase in the channel size for mut1 and a decrease in the channel size for mut2 in comparison with wild type. While epothilone binding site remains undisturbed with the residual substitution. Here we hypothesized that the drug resistivity especially for taxol binding drugs could be due to the conformational changes in the active site pocket due to residual mutations.
Conclusion
The residual interaction analysis in wild and the mutants of taxol and epothilone binding 
